CEO Today - USA Awards 2022

At Horizon, we believe science and compassion must work together to transform lives. Our mission to deliver medicines for rare, autoimmune and severe inflammatory diseases and provide compassionate support comes from our strong and simple philosophy to make a meaningful difference for patients and communities in need. Our story began long before Horizon was founded in 2008. In college, CEO Tim Walbert was diagnosed with an autoimmune condition and 10 years later, after seeing more than 100 physicians, was diagnosed with a rare disease. Horizon is so much more than a business to Tim. It’s an investment in his future and the future of other people living with rare diseases. For him, Horizon is as personal as it gets. Horizon started with a handful of employees and no office space. Though we’ve grown, our culture is no different today than it was when we started. At Horizon, we think differently about research and development (R&D). Our willingness to take calculated risks allows us to deliver transformational medicines for patients with rare, autoimmune and severe inflammatory diseases. We apply extensive research experience to target, design and execute R&D programs that explore the connections between science and disease states to both develop and deliver breakthrough treatments that will have a profound impact on underserved patients who don’t have many, if any, options. Our approach also allows us to maximize the potential of medicines under our care. We believe that what we can do together is better than what we can do alone. Our diverse and nimble team is what makes us unique. We operate with an entrepreneurial mindset that unites collaboration and innovation. Horizon’s scientists work seamlessly and quickly with colleagues in technical operations, medical affairs and commercial to develop and deliver meaningful medicines for patients with serious unmet medical needs. At Horizon, we put patients first. We’re committed to improving lives by discovering, developing and bringing to market medicines that address unmet medical needs. But our commitment extends beyond our medicines. At our core, we believe science and compassion must work together to transform lives. We actively partner with multiple organizations to raise awareness for many underrepresented diseases and to advocate on behalf of patients and their communities. Tim Walbert Chairman, President and CEO Horizon Therapeutics CEO Today USA Award s 2022 - ILLINOIS - - 43 - PHARMACEUTICALS LEADER OF THE YEAR

RkJQdWJsaXNoZXIy Mjk3Mzkz